- Home
- QUCY vs SPHL Comparison
QUCY vs SPHL Comparison
Compare QUCY & SPHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | QUCY | SPHL |
|---|---|---|
| Founded | 2008 | 2002 |
| Country | Germany | Singapore |
| Employees | 13 | 71 |
| Industry | | Homebuilding |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9M | 6.1M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | QUCY | SPHL |
|---|---|---|
| Price | $0.51 | $2.31 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 346.5K | 9.8K |
| Earning Date | 03-31-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $74.34 | N/A |
| Revenue Next Year | $171.48 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.40 | $0.35 |
| 52 Week High | $0.74 | $25.11 |
Technical Indicators
Market Signals| Indicator | QUCY | SPHL |
|---|---|---|
| Relative Strength Index (RSI) | 44.46 | 40.01 |
| Support Level | $0.43 | $2.18 |
| Resistance Level | $0.53 | $3.11 |
| Average True Range (ATR) | 0.07 | 0.21 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 28.54 | 13.43 |
Price Performance
Historical ComparisonAbout QUCY Mainz Biomed N.V. Ordinary Shares
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.
About SPHL Springview Holdings Ltd Class A Ordinary Shares
Springview Holdings Ltd is a company that conducts its operations through its indirect wholly-owned subsidiary which designs and constructs residential and commercial buildings in Singapore. It also provides four main types of works which includes new construction, reconstruction, Additions and Alterations (A&A), and other general contracting services such as renovation and design consultation. The company operates and manages its business as a single segment - in the development of construction projects. It derives maximum revenue from its Residential Customers.